1. Introduction {#sec0005}
===============

1.1. Neuronal activity in the brain fluctuates rhythmically and synchronously {#sec0010}
-----------------------------------------------------------------------------

In the hippocampus, oscillations at theta frequency (θ: 3--8 Hz) and gamma frequency (γ: 30--120 Hz) are prominent during exploration ([@bib0040]; [@bib0070]). Hippocampal cornu ammonis area 1 (CA1) receives its major inputs from cornu ammonis area 3 (CA3) and from the medial entorhinal cortex (MEC). The 'routing by synchrony' hypothesis proposes that information flow between areas is dynamically modulated by the level of phase-locking of the oscillations in these areas ([@bib0095]). During exploration, γ synchronization in CA1 varies in its frequency content, with low-frequency γ oscillations (slow γ: 30--60 Hz) phase-locked with slow γ in CA3, and medium-/high-frequency γ oscillations (fast γ: 60--120 Hz), prominent when CA1 receives the strongest inputs from the MEC ([@bib0190]; [@bib0205]). Slow γ and fast γ are prominent at different phases of the θ oscillation ([@bib0065]), suggesting that, timed by the θ oscillation, CA1 alternatively tunes in to CA3 and MEC ([@bib0205]). θ coordinates the encoding and retrieval of episodic and spatial memories ([@bib0125]; [@bib0140]). It was therefore proposed that CA3 to CA1 routing of information by phase-coupled slow γ is involved in memory retrieval, whereas MEC to CA1 information routing during fast γ is associated with encoding of new information ([@bib0015]; [@bib0025]). This implies that alternating slow γ and fast γ states allows the hippocampus to switch between prospective and retrospective modes, possibly to prevent interference between memory retrieval and encoding ([@bib0055]).

It is therefore important to understand what mechanisms underlie the switch of the CA1 network between slow γ and fast γ. Slow γ in CA1 has been shown to be driven by CA3 in vitro ([@bib0085]; [@bib0090]) and in vivo ([@bib0035]), through feed-forward inhibition by parvalbumin-expressing (PV+) interneurons and bi-stratified interneurons ([@bib0020]; [@bib0225]; [@bib0240]). However, during fast γ, pyramidal CA1 firing is synchronized by local interneurons ([@bib0065]; [@bib0210]). It was therefore proposed that "in the absence of particularly strong activation of CA3, the default gamma mode in CA1 during active behaviors may be fast gamma oscillations" ([@bib0060]). Indeed, when disconnected from CA3, the CA1 network generates intrinsic fast γ through feedback inhibition ([@bib0020]; [@bib0185]; [@bib0195]), which can be suppressed by low-intensity 33 Hz Schaffer collateral stimulation, mimicking slow γ input from CA3 ([@bib0195]).

The excitability of feed-forward interneurons may be controlled by θ phase-linked modulation ([@bib0235]), possibly through activation of μ opioid receptors (MOR) expressed on PV + interneurons ([@bib0080]; [@bib0215]) that inhibit GABAergic inhibitory postsynaptic responses in CA1 pyramidal neurons ([@bib0115]; [@bib0160]; [@bib0170]). Enkephalin release from enkephalin-expressing interneurons in area CA1 is modulated by the θ phase ([@bib0105]) and targets PV + interneurons ([@bib0030]; [@bib0105]), which may mediate the θ phase modulation of fast γ and slow γ in CA1. MORs are also expressed on neurogliaform and Ivy cells ([@bib0150]), but given the low frequency and slow kinetics of IPSCs elicited by these cells, their contribution to rhythm generation and exact timing of γ is limited ([@bib0005]; [@bib0200]; [@bib0100]).

To investigate the role of MOR activation in the switch between fast γ and slow γ in CA1, we tested the effect of activation or inhibition of MOR in hippocampal slices.

2. Experimental procedures {#sec0015}
==========================

2.1. Animals {#sec0020}
------------

Adult male Wistar rats (200--300 g) were used for in vitro experiments. All procedures conformed to the UK Animals (Scientific Procedures) Act 1986 and were approved by the Biomedical Ethics Review Sub-committee of the University of Birmingham and by the Animal ethics and administrative council of Henan province, P.R. China. All efforts were made to minimize animal suffering and to reduce the number of animals used.

2.2. Hippocampal slice preparation {#sec0025}
----------------------------------

Rats were anesthetized by intraperitoneal injection of a ketamine (75 mg kg^-1^)/ medetomidine (1 mg kg^-1^) mixture and killed by cardiac perfusion with a chilled sucrose-based solution, consisting of 205 mM sucrose, 2.5 mM KCl, 26 mM NaHCO~3~, 1.2 mM NaH~2~PO~4~, 0.1 mM CaCl~2~, 5 mM MgCl~2~ and 10 mM *D*-glucose; pH set at 7.4 by gassing with carbogen (95% O~2~-5% CO~2~). The brain was glued upside-down and horizontal slices (400 μm thick) were cut (from 4.5 mm to 6.5 mm ventral from bregma) in chilled sucrose-based solution, using an Integraslicer (Campden Instruments, Loughborough, UK) vibrating ceramic blade slicer. Slices from the left hippocampus, including the whole hippocampus and overlaying neocortex ([Supplemental Materials 1 panel A](#sec0180)), were immediately placed in the Haas-type interface recording chamber (kept at 32 °C), which was perfused (7 ml/min) with artificial cerebrospinal fluid (aCSF) and covered with warm, moist carbogen (0.3 l/min). The aCSF consisted of 125 mM NaCl, 3 mM KCl, 26 mM NaHCO~3~, 1.25 mM NaH~2~PO~4~, 2 mM CaCl~2~, 1 mM MgCl~2~ and 10 mM *D*-glucose and was saturated with carbogen, keeping the pH at 7.4. Slices from the right hippocampus were trimmed with scalpel cuts to obtain isolated CA1 minislices, in which the CA1 cell line was kept intact, but subiculum and CA2 was kept to a minimum ([Supplemental Materials 1 panel B](#sec0180)). CA1 minislices were maintained in an interface type storage chamber, kept at 21 °C for later use.

2.3. Field potential recording of gamma oscillations {#sec0030}
----------------------------------------------------

Field potentials were recorded using aCSF-filled glass pipette recording electrodes (4--5 MΩ), amplified with Neurolog NL104 AC-coupled amplifiers (Digitimer, Welwyn Garden City, UK) and band-pass filtered at 2 Hz--500 Hz with Neurolog NL125 filters (Digitimer). After main line noise (50 Hz) was eliminated with Humbug noise eliminators (Digitimer), the signal was digitized and sampled at 2 kHz using a CED-1401 (Cambridge Electronic Design, Cambridge, UK) and Spike-2 software (Cambridge Electronic Design).

Gamma (γ) oscillations were induced by carbachol (5 μM) after 60 min of rest and left to develop for 60 min. In some experiments drugs were applied to either CA1 or CA3 and diffusion from CA3 to CA1 was prevented by placing a hair covered in vacuum grease (Down Corning, Midland, USA) over CA2 ([Supplemental Materials Fig. 2](#sec0180)). A glass micropipette was filled with freshly gassed aCSF, with or without drug, at a concentration 40 times the concentration used for bath application. Addition of 0.1 mM Evans blue allowed to monitor the spread of fluid applied. The tip was broken up to the point that a minimal amount of aCSF would flow out by gravity, when touching the fluid film covering the slice. The drug was applied by a swiping movement following the cell line avoiding accumulation of fluid in one place. After 5 min the application was stopped by lifting the pipette.

2.4. Drugs {#sec0035}
----------

Drugs were added to the aCSF, diluted from the following stock solutions: The muscarinic acetylcholine receptor agonist carbamylcholine chloride (carbachol), 10 mM in H~2~O; the μ--opioid receptor agonist the \[D-Ala^2^, NMe-Phe^4^, Gly-ol^5^\]-enkephalin (DAMGO), 1 mM in H~2~O; the competitive μ--opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP), 0.2 mM in H~2~O; the voltage-sensitive sodium channel blocker tetrodotoxin citrate (TTX), 1 mM in H~2~O. DAMGO and CTAP were purchased from Tocris (Bristol, UK). All other drugs and aCSF salts were purchased from Sigma (Poole, UK). In control experiments equivalent vehicle (H~2~O) applications were made.

2.5. Data analysis {#sec0040}
------------------

Data analysis was done using Spike-2 (Cambridge Electronic Design) and MatLab (MathWorks, Natick, USA). In vitro recordings were band-pass filtered at 15--40 Hz for the slow γ band and at 40--80 Hz for the fast γ band, using a frequency-true filter with 5 Hz edge. The oscillation power was calculated over ≥60 s unfiltered recording epochs by fast Fourier transforms (1 Hz bin size, Hanning window).

To determine the relationship between oscillations recorded in CA1 and CA3, the cross-correlation and the phase-locking value (PLV) were calculated. Waveform cross-correlograms, with CA3 as reference, were calculated over 300 s epochs of band pass-filtered recordings. PLV analysis was done by a method adapted from [@bib0155]. From band pass-filtered recordings from CA1 and CA3, a Hilbert transform provided the phase of each time point (φs) and the difference in φs between the two signals (*δ*φs) was calculated for all time points. The phase-locking index was calculated over 10 s epochs with 5 s overlap to provide a time series of the PLV (ranging between 1: completely locked *δ*φs and 0: completely random *δ*φs). Event-related potentials (ERPs) were constructed by taking waveform averages of the unfiltered recording from CA1 or CA3, time-zeroed by the troughs of medium-large amplitude waves in the γ band pass-filtered recording from CA3. Care was taken to select the same size troughs before and after drug application, by setting an upper limit to the 5% largest waves at baseline and a lower limit as 50% of the upper limit.

2.6. Statistics {#sec0045}
---------------

Data sets were found to be normally distributed and are expressed as mean ± standard error of the mean (s.e.m.). Statistical comparisons between experimental groups were made using unpaired Student\'s *t*-tests and between different conditions within one cell using paired Student\'s *t*-tests. Effects were considered significant if *P* \<  0.05. Statistical analysis was done using SPSS (SPSS Inc., Chicago, USA).

3. Results {#sec0050}
==========

3.1. Effect of MOR modulation on γ oscillations in CA1 minislices {#sec0055}
-----------------------------------------------------------------

### 3.1.1. Intrinsic CA1 γ oscillation characteristics {#sec0060}

The neuronal network in CA1, when anatomically isolated from area CA3, is known to generate its own intrinsic γ oscillation that is faster than the γ oscillation generated by the CA3 neuronal network and independent of subicular activity ([@bib0020]; [@bib0185]; Pietersen, et al., 2014). Oscillatory activity was induced in CA1 minislices by adding the cholinergic receptor agonist carbachol (5 μM) to the aCSF ([@bib0195]). Recordings were made from the stratum oriens-stratum pyramidale border, where the power of intrinsic fast γ was found to be maximal ([@bib0195]). Out of six CA1 slices placed in the recording chamber, two were selected that had developed the strongest γ oscillations (example in [Fig. 1](#fig0005){ref-type="fig"}A). Taking into account the temperature dependence of gamma oscillations ([@bib0075]), we defined the γ band as 15--80 Hz, the slow γ band as 15--40 Hz and the fast γ band as 40--80 Hz. In 26 control slices the average power in the slow γ band (slow γ power) was 7.5 ± 1.2 μV^2^, the fast γ power was 7.0 ± 1.0 μV^2^ and the dominant frequency was 44.1 ± 0.7 Hz.Fig. 1**MOR activation decelerates γ oscillations in CA1 minislices. A.** Typical recordings from a CA1 minislice (see [Supplemental Materials 1](#sec0180)) show oscillatory activity before (blue trace) and after (red trace) application of the MOR agonist DAMGO (1 μM). **B.** Power spectra of the recordings in (A) before (blue line), 3--5 minutes (purple line) and 25--30 minutes (red line) after DAMGO application. Shows the bi-phasic nature of the effect of MOR activation on power in the γ range. **C.** The change in γ power (15--80 Hz) as function of time after application of DAMGO (n = 11, red symbols), the MOR antagonist CTAP (200 nM, n = 8, green symbols) or vehicle (n = 8, blue symbols), shows a large variability in the effect of DAMGO on γ power. Data show average and s.e.m. **D.** The change in dominant frequency as function of time after application of DAMGO, CTAP or vehicle. Details as in C. DAMGO causes a consistent early deceleration of the γ oscillation (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).Fig. 1

### 3.1.2. The effect of MOR modulation on CA1 γ power and frequency {#sec0065}

We tested the effect of the MOR agonist DAMGO and the competitive MOR antagonist CTAP on the γ oscillations in CA1 minislices, one hour after application of carbachol. All effects of drugs are expressed as changes, normalized to the five minutes before drug application (baseline) and compared to similar changes in response to vehicle application (control) that showed small, but systematic changes with time. In eight control slices, γ power (average power in the 15--80 Hz band) gradually increased by 21 ± 4% relative to baseline (t~(7)~= −2.98, P = 0.020) over 30 min after vehicle application and the dominant frequency increased by 1.3 ± 0.5 Hz (t~(7)~= −2.41, *P*= 0.047). Application of DAMGO (1 μM) did not affect γ power consistently; four slices responded with an initial suppression, followed by a later increase in γ power (example in [Fig. 1](#fig0005){ref-type="fig"}B), two slices only had the early suppression and two slices only showed a power increase. [Fig. 1](#fig0005){ref-type="fig"}C gives the average change in γ power, showing a biphasic effect, suggesting that the contribution of an early suppressive effect and the late enhancing effect of DAMGO differs per slice. After 30 min, γ power was 146 ± 22% of baseline (t~(10)~= −1.28, P = 0.228) and not different from the change in control slices (t~(17)~= −0.96, P = 0.350). However, there was a consistent reduction in the dominant frequency in the first five minutes (by −3.8 ± 1.4 Hz, t~(10)~ = 2.70, P = 0.022), which gradually recovered and was −1.8 ± 1.2 Hz from baseline after 30 min (t~(10)~ = 1.64, P = 0.131, [Fig. 1](#fig0005){ref-type="fig"}D), different from the small increase in frequency observed in control slices (t~17~ = 2.90, P = 0.020). Application of CTAP (200 nM) had no effect on γ power (114 ± 4% of baseline, t~(7)~ = 1.49, P = 0.181, not different from changes in control slices, t~(14)~ = 0.70 P = 0.496, [Fig. 1](#fig0005){ref-type="fig"}C), or on dominant frequency (t~(14)~ = 1.09, P = 0.294 compared to control, [Fig. 1](#fig0005){ref-type="fig"}D), suggesting that, under our experimental conditions, MORs are not activated by endogenous MOR ligands.

3.2. MOR modulation uncouples slow γ oscillations in intact hippocampal slices {#sec0070}
------------------------------------------------------------------------------

### 3.2.1. CA1 has CA3-driven slow γ and intrinsic fast γ {#sec0075}

Oscillatory activity was induced in intact hippocampal slices by adding carbachol (5 μM) to the aCSF. Recordings were made from CA3c stratum pyramidale and from the stratum pyramidale/stratum oriens border in CA1a, where the power of intrinsic fast γ was found to be largest ([@bib0195]). The oscillation was normally very regular in area CA3 (example in [Fig. 2](#fig0010){ref-type="fig"}A) with clear power peak in the slow γ band (28.4 ± 0.3 Hz, n = 23) and second peak in the fast γ band ([Fig. 2](#fig0010){ref-type="fig"}B). Because the peak frequency of the fast γ peak was always double that of the dominant frequency of the slow γ peak, and slow γ power and fast γ power covaried strongly within slices, the second peak is assumed to be the second harmonic, reflecting the saw tooth shape of the γ waveform. However, in area CA1 of the same slice the oscillation was very irregular (example in [Fig. 2](#fig0010){ref-type="fig"}A) and the power spectrum often had two distinct peaks: one with a peak frequency identical to the dominant frequency of CA3 slow γ and a shoulder or peak at higher frequencies (35--55 Hz, example in [Fig. 2](#fig0010){ref-type="fig"}B). From the three slices placed in the recording chamber, the one with the largest CA1 fast γ/CA1 slow γ ratio was selected for further analysis and pharmacological experiments. The slow γ power in CA1 covaries with the CA3 slow γ power, but not with the fast γ power in CA1 ([@bib0195]), suggesting that, in part, the CA1 slow γ is driven by CA3 slow γ. If CA3 slow γ drives CA1 slow γ through Schaffer collateral-mediated inputs ([@bib0035]; [@bib0085]; [@bib0090]), it is expected that the phase of the oscillation in both networks is coupled. To test this, the phase-locking value (PLV) between the CA1 signal and CA3 signal was determined. The PLV for the slow γ band was substantial (0.38 ± 0.02, n = 23), but the PLV for the fast γ band was weak (0.12 ± 0.01). In line with this, the amplitude (peak nearest to 0 ms minus following trough) of the cross-correlation between CA3 and CA1, was substantial for the slow γ band (0.78 ± 0.04), with a phase difference (time of the cross-correlation minimum) of 9.6 ± 0.4 ms, but the cross-correlation amplitude was small for the fast γ band (0.14 ± 0.02). The synchronous firing of CA3 pyramidal cells underlying CA3 slow γ, is driving slow γ in CA1 through feed-forward inhibition ([@bib0135]). In order to investigate the CA3 slow γ-driven, Schaffer collateral-mediated influence on the oscillation in CA1, event-related potentials (ERPs) were constructed. Because CA3 pyramidal neurons fire close to the γ wave troughs recorded in CA3 stratum pyramidale ([@bib0090]), CA3-CA1 ERPs were constructed using the trough of medium-large size slow γ waves in CA3 stratum pyramidale as trigger (example in [Fig. 2](#fig0010){ref-type="fig"}E). These CA3-CA1 ERPs represent both Schaffer collateral-mediated excitatory postsynaptic currents (EPSCs) and feed-forward inhibitory postsynaptic currents (IPSCs). The ERP had a minimum of 28 ± 5 μV at 18 ± 2 ms after the population spike in CA3. These observations indicate that, in the intact slice, CA1 slow γ is, in part, phase-coupled to CA3 slow γ through Schaffer collateral inputs, whereas CA1 fast γ is mostly independent of the CA3 oscillation.Fig. 2**MOR activation uncouples γ oscillations in CA1 from γ oscillations in CA3. A.** Typical recordings from area CA3 and CA1 of an intact hippocampal slice (see [Supplemental Materials 1](#sec0180)). At baseline (blue traces) CA3 displays slow γ and CA1 a mixture of slow γ and fast γ. DAMGO application decelerates CA3 slow γ and increases the fast γ content in the CA1 recording. **B.** Power spectra of recordings in CA3 (top panel) and CA1 (bottom panel) of slice in (A) before (blue lines) and after DAMGO application (red lines). DAMGO shifts the slow γ power peak in CA3 and shifts and reduces the CA3-linked slow γ power peak in CA1 (arrow). **C.** Example of the phase-locking value (PLV) between CA3 and CA1 recordings of slice in (A), for the slow γ band (black line) and the fast γ band (grey line). DAMGO application caused a strong reduction of the slow γ PLV and a small reduction of the fast γ PLV. **D.** Histogram of the PLV for the slow γ band and fast γ band, before (blue bars), and 2--3 minutes (purple bars) and 25--30 minutes (red bars) after DAMGO application. Data are average and s.e.m. of 10 slices. **E.** ERPs in CA3 (top panel) and CA1 (bottom panel) of slice in (A), time-zeroed by the trough of medium-large-size slow γ waves in CA3 (dotted line), before (blue lines) and after DAMGO application (red lines). DAMGO reduces the slow late ERP and unmasks an earlier ERP component (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).Fig. 2

### 3.2.2. The effect of MOR modulation on CA3 γ power and frequency {#sec0080}

In the mouse hippocampus slices, DAMGO reduced carbachol-induced CA3 γ power, without affecting its dominant frequency ([@bib0120]). Our prediction was to observe a similar effect in rat hippocampus slices. However, DAMGO (1 μM) did not consistently affect CA3 γ power. Seven out of ten slices had biphasic changes in CA3 slow γ power, with an early increase and later decrease, suggesting opposing effects. The remaining slices had an initial decrease followed by an increase. At 25--30 minutes after DAMGO application, CA3 slow γ was 159 ± 28% of baseline (t~(9)~ = 1.14, P = 0.296). In each slice the dominant frequency of CA3 slow γ shifted quickly, on average by −9.7 ± 0.4 Hz (t~(9)~ = 24.65, P\< 0.001).

### 3.2.3. The effect of MOR modulation on the CA3-driven slow γ power in CA1 {#sec0085}

In the same slices, the CA3-driven slow γ power peak in CA1 shifted to a similar frequency as in CA3, but was strongly reduced in amplitude, both in slices where DAMGO decreased CA3 slow γ power, as well as in slices where DAMGO increased CA3 slow γ power (example in [Fig. 2](#fig0010){ref-type="fig"}B). To quantify this effect, the CA3 dominant frequency power (power in the range -5 Hz to +5 Hz from the dominant frequency in CA3) in CA1 was divided by the CA3 dominant frequency power in CA3. DAMGO reduced this CA3 dominant frequency power ratio to 37 ± 6% of that at baseline (t~(9)~ = 6.22, P\< 0.001, example in [Fig. 2](#fig0010){ref-type="fig"}B). This suggests that activation of MORs uncouples oscillatory activity in CA1 from the slow γ in CA3. DAMGO increased the CA1 fast γ power/CA1 slow γ power ratio by 42 ± 11% (t~(9)~= −3.38, P = 0.008), indicating that the DAMGO-induced uncoupling of oscillatory activity in CA1 from CA3 slow γ, reduces the suppressive effect of CA3 slow γ on intrinsic fast γ in CA1, as demonstrated previously ([@bib0195], see also [Supplemental Materials 2](#sec0180)).

### 3.2.4. The effect of MOR modulation on phase-coupling between CA3 γ and CA1 γ {#sec0090}

To test the functional uncoupling of oscillatory activity in CA1 from CA3 slow γ by DAMGO, we first tested the effect of DAMGO on the PLV between the CA1 signal and the CA3 signal. In all slices where DAMGO caused an increase in CA3 slow γ power, the slow γ PLV transiently increased, to a maximum of 157 ± 8% of baseline (t~(6)~= -8.79, P\< 0.001) at 2--3 minutes after application, after which it decreased (example in [Fig. 2](#fig0010){ref-type="fig"}C). In the remaining slices the slow γ PLV only decreased upon DAMGO application. Taken from its maximum value (either at baseline or after 2--3 minutes), DAMGO reduced the slow γ PLV by 70 ± 3% (t~(9)~ = 10.46, P\< 0.001, [Fig. 2](#fig0010){ref-type="fig"}D). In contrast DAMGO application had no consistent effect on the fast γ PLV (83 ± 10% of baseline (t~(9)~ = 1.65, P = 0.134, [Fig. 2](#fig0010){ref-type="fig"}C,D). These observations confirm that MOR activation can functionally uncouple γ in CA1 from CA3 slow γ.

### 3.2.5. The effect of MOR modulation on CA3-driven synaptic potentials in CA1 {#sec0095}

Because the PLV analysis does not address any DAMGO-induced change in directionality or nature of the CA3-CA1 coupling, this was assessed by cross-correlation and ERP analysis. DAMGO shifted the time of the cross-correlation minimum by -16 ± 4 ms (t~(9)~ = 3.84, P = 0.004), suggesting that the response of the CA1 network to CA3 inputs changed in nature. In order to analyze the effect of DAMGO on the CA3-CA1 ERP, CA3 slow γ waves were selected at a fixed medium-large amplitude range, set at baseline. The CA3 waveform average of selected slow γ waves demonstrates that, despite a change in CA3 slow γ power, the trigger for the CA3-CA1 ERP in DAMGO is the same as at baseline ([Fig. 2](#fig0010){ref-type="fig"}E, top panel). If MORs are selectively expressed on interneurons ([@bib0080]; [@bib0215]), the prediction is that MOR activation would reduce the feed-forward IPSC, but would not affect the EPSC. Indeed, DAMGO reduced the CA3-CA1 ERP amplitude at the time of the trough at baseline by 82 ± 3% (t~(9)~= −7.18, P\< 0.001), unmasking an earlier component (trough moved by −11 ± 1 ms, t~(9)~ = 11.24, P\< 0.001) that was only visible as a notch in the waveform at baseline (example in [Fig. 2](#fig0010){ref-type="fig"}E, bottom panel). The earlier component is likely to reflect the CA3-CA1 EPSC, unmasked by suppression of the subsequent feed-forward IPSC. These observations confirm that activation of MORs suppresses the feed-forward inhibition-driven slow γ in CA1, which can cause the loss of phase-coupling between CA3 slow γ and CA1 slow γ.

3.3. The effect of DAMGO is MOR-specific {#sec0100}
----------------------------------------

To test the selectivity of MOR activation in the effect of DAMGO, we repeated the experiment in the presence of a high concentration of the competitive MOR antagonist CTAP (500 nM, applied 20 min before DAMGO). CTAP did not affect CA3 slow γ power (116 ± 11% of baseline (t~(5)~= −1.53, P = 0.187, example in [Fig. 3](#fig0015){ref-type="fig"}C), the dominant frequency of CA3 slow γ (0.2 ± 0.4 Hz from baseline, t~(5)~ = 0.42, P = 0.695), the CA3 dominant frequency power ratio (91 ± 4% of baseline, t~(5)~ = 2.07, P = 0.093), the slow γ PLV (106 ± 3% of baseline, t~(5)~= -1.94, P = 0.110, [Fig. 3](#fig0015){ref-type="fig"}B), the slow γ cross-correlation phase-difference (trough was 1.2 ± 0.7 ms from that at baseline, t~(5)~= −1.58, P = 0.180), or the ERP amplitude at the time of the trough at baseline (108 ± 8% of baseline, t~(5)~ = 1.01, P = 0.358, example in [Fig. 3](#fig0015){ref-type="fig"}C). In the presence of CTAP, DAMGO did not affect CA3 slow γ power (139 ± 23% of CTAP baseline, t~(5)~= −1.80, P = 0.132), but shifted the dominant frequency of CA3 slow γ by −2.3 ± 0.2 Hz from that at CTAP baseline (t~(5)~= −11.07, P\< 0.001, example in [Fig. 3](#fig0015){ref-type="fig"}A), significantly less than the shift in the absence of CTAP (t~(14)~ = 22.90, P\< 0.001). In the presence of CTAP, DAMGO did not affect the CA3 dominant frequency power ratio (121 ± 21% of CTAP baseline, t~(5)~= -0.64, P = 0.552), the slow γ PLV (98 ± 8% of baseline, t~(5)~ = 0.21, P = 0.840, [Fig. 3](#fig0015){ref-type="fig"}B), the slow γ cross-correlation phase-difference (trough was 1.0 ± 0.5 ms from that at CTAP baseline, t~(5)~ = 1.94, P = 0.111), or the ERP amplitude at the time of the trough at CTAP baseline (109 ± 4% of CTAP baseline, t~(5)~= −1.71, P = 0.149, example in [Fig. 3](#fig0015){ref-type="fig"}C). Although the competitive MOR antagonist CTAP did not completely prevent the shift in CA3 slow γ dominant frequency, it prevented the phase uncoupling observed with DAMGO alone, confirming that this effect is MOR-selective.Fig. 3**DAMGO application in the presence of CTAP fails to uncouple CA1 γ from CA3 slow γ. A.** Example of the effect of application of DAMGO (1 μM), 20 min after application of the competitive MOR antagonist CTAP (500 nM), on the power spectrum of recordings from CA3 (top panel) and CA1 (bottom panel), before (blue lines) and after CTAP application (green lines) and after addition of DAMGO (red lines). In the presence of CTAP, DAMGO does not suppress the CA3-linked slow γ power peak in CA1. **B.** Histogram of the PLV for the slow γ band and fast γ band, at baseline (blue bars), after CTAP application (green bars) and after DAMGO application (red bars). Data are average and s.e.m. of 6 slices. **C.** Example of an ERP in CA1 time-zeroed by th CA3 trough-(dotted line) at baseline, in the presence of CTAP and after DAMGO application (details as in A). In the presence of CTAP, DAMGO application did not affect the ERP. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).Fig. 3

3.4. Effect of frequency change cannot explain the uncoupling {#sec0105}
-------------------------------------------------------------

Because the suppression of intrinsic CA1 fast γ by CA3-generated slow γ is dependent on the frequency of Schaffer collateral inputs ([@bib0195]), it is possible that the DAMGO-induced reduction of phase-coupling between CA3 slow γ and CA1 slow γ is caused by the reduced frequency of CA3 slow γ, which would allow the emergence of intrinsic CA1 fast γ. To test this, we used the benzodiazepine zolpidem that is known to reduce the frequency of CA3 slow γ by decreasing the IPSC decay rate ([@bib0135]). Like the effect of DAMGO, zolpidem (1 μM) decreased the dominant frequency of CA3 slow γ in seven slices tested by -5.5 ± 0.6 Hz (t~(6)~ = 8.90, P\< 0.001) and shifted the CA3-driven slow γ power peak in CA1 by the same amount (example in [Fig. 4](#fig0020){ref-type="fig"}A). Zolpidem increased CA3 slow γ power by 25 ± 5%, which was not different from the change in vehicle controls (18 ± 2%, t~(15)~ = 1.02, P = 0.325). However, in contrast to the effect of DAMGO, zolpidem slightly increased the CA3 dominant frequency power in CA1 (to 122 ± 10% of baseline, t~(6)~= -1.55, P = 0.172) and increased the CA3 dominant frequency power ratio by 27 ± 4% (t~(6)~ = 6.22, P\< 0.001, example in [Fig. 4](#fig0020){ref-type="fig"}A). Zolpidem did not affect the slow γ PLV (88 ± 8% of baseline, t~(6)~ = 1.57, P\< 0.177, [Fig. 4](#fig0020){ref-type="fig"}B), or the slow γ cross-correlation phase difference (trough was 1.3 ± 0.6 ms from that at baseline, t~(6)~= -2.07, P = 0.084). Zolpidem reduced the CA3-CA1 ERP amplitude at the time of the trough at baseline slightly (to 78.8 ± 4.0% of baseline, t~(6)~= −2.17, P = 0.073), significantly less than the DAMGO-induced change (t~(15)~ = 7.52, P\< 0.001). Zolpidem did not affect the ERP trough time (shifted by 2.1 ± 0.4 ms, t~(6)~= -2.07, P = 0.084) and waveform shape (example in [Fig. 4](#fig0020){ref-type="fig"}C). These observations indicate that the DAMGO-induced uncoupling of CA1 γ is not the result of the reduced dominant frequency of slow γ in CA3.Fig. 4**Deceleration of CA3 slow γ fails to uncouple CA1 γ from CA3 slow γ. A.** Example of the effect of zolpidem on the power spectrum of recordings from CA3 (top panel) and CA1 (bottom panel), before (blue lines) and after application of zolpidem (1 μM, red lines). Zolpidem decelerates CA3 slow γ and shifts the CA3-linked slow γ power peak in CA1, without affecting γ power in CA1. **B.** Histogram of the PLV for the slow γ band and fast γ band, before (blue bars), and 2--3 minutes (purple bars) and 25--30 minutes (red bars) after zolpidem application. Data are average and s.e.m. of 7 slices. **C.** Example of an ERP in CA1, time-zeroed by the CA3 trough-(dotted line) before (blue line) and after zolpidem application (red line). Zolpidem did not affect the ERP (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).Fig. 4

3.5. Local application of DAMGO identifies the effect location {#sec0110}
--------------------------------------------------------------

### 3.5.1. Local application of drugs {#sec0115}

In order to determine where in the hippocampal network DAMGO causes the uncoupling of CA1 gamma from slow γ in CA3, we applied DAMGO selectively in area CA3 or in area CA1, with the fluid film on top of the slice divided by a greased hair ([Supplemental Materials 2 panel A](#sec0180)). To ensure that the drug application would affect the entire area of interest, without spreading across the greased hair barrier, we tested the effect of TTX application (for five minutes) by a gravity fed large-tip application pipette ([Supplemental Materials 2](#sec0180)). Application of TTX to area CA3 not only validated the method, but demonstrated, in line with our previous report ([@bib0195]), that the disappearance of the CA3 gamma-driven input to CA1 unmasked the intrinsic fast γ in CA1.

### 3.5.2. The effect of MOR modulation in CA3 only {#sec0120}

Application of DAMGO (40 μM) to the entire CA3 stratum pyramidale, but avoiding CA1, decreased the dominant frequency of slow γ in CA3 by 10.6 ± 1.4 Hz (t~(6)~ = 7.67, P\< 0.001, example in [Fig. 5](#fig0025){ref-type="fig"}A), not different from the shift induced by bath application of DAMGO (t~(15)~ = 0.72, P = 0.485). The CA3 slow γ power increased by 49 ± 19% (t~(6)~= -2.49, P = 0.047). However, in contrast to bath application of DAMGO, but similar to the effect of zolpidem, local application of DAMGO to CA3 did only shift, but not reduce the CA3 slow γ power peak in CA1 (example in [Fig. 5](#fig0025){ref-type="fig"}A). DAMGO in CA3 increased the slow γ PLV (by 33 ± 8%, t~(6)~ = 4.02, P = 0.007, [Fig. 5](#fig0025){ref-type="fig"}B/C), but did not affect the CA3 dominant frequency power ratio (106 ± 4% of baseline, t~(6)~= −0.33, P = 0.751), or the slow γ cross-correlation phase difference (trough was 1.0 ± 0.6 ms from that at baseline, t~(6)~ = 1.73, P = 0.144). DAMGO in CA3 did not affect the CA3-CA1 ERP amplitude at the time of the trough at baseline (to 111 ± 8% of baseline, t~(6)~ = 1.43, P = 0.204, example in [Fig. 5](#fig0025){ref-type="fig"}D). If anything, DAMGO applied to CA3 only increased the phase-coupling between CA3 and CA1 γ.Fig. 5**DAMGO application to CA3 decelerates CA3 slow γ but fails to uncouple CA1 γ from CA3 slow γ. A.** Example of the effect of application of DAMGO to the CA3 area only, using the greased hair as diffusion barrier, on the power spectrum of recordings from CA3 (top panel) and CA1 (bottom panel), before (blue lines) and after local application of DAMGO (red lines). DAMGO in CA3 decelerates CA3 slow γ and shifts the CA3-linked slow γ power peak in CA1, without affecting γ power in CA1. **B.** Example of the phase-locking value (PLV) between CA3 and CA1 recordings of slice in (A), for the slow γ band (black line) and the fast γ band (grey line). Data are. **C.** Histogram of the PLV for the slow γ band and fast γ band, at baseline (blue bars) and after DAMGO application to CA3 (red bars). Data are average and s.e.m. of 7 slices. **D.** Example of an ERP in CA1 time-zeroed by the CA3 trough(dotted line), before (blue line) and after DAMGO application (red line). DAMGO application to CA3 did not affect the ERP (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).Fig. 5

### 3.5.3. The effect of MOR modulation in CA1 only {#sec0125}

Application of DAMGO to the CA1 area recorded from, while avoiding CA3 with the greased hair method, had no effect on CA3 slow γ power (t~(6)~= -1.66, P = 0.148) or dominant frequency (t~(6)~ = 0.00, P = 0.999), but suppressed the CA3-driven slow γ power peak in CA1 (example in [Fig. 6](#fig0030){ref-type="fig"}A). The CA3 dominant frequency power ratio was reduced by 56 ± 6% from that at baseline (t~(6)~ = 4.04, P = 0.007). DAMGO in CA1 reduced the slow γ PLV (by -67 ± 9%, t~(6)~ = 5.82, P = 0.001, [Fig. 6](#fig0030){ref-type="fig"}B/C), but the slow γ cross correlation phase difference was not different (trough was 1.2 ± 1.4 ms from that at baseline, t~(6)~ = 0.88, P = 0.414). DAMGO in CA1 reduced the CA3-CA1 ERP amplitude at the time of the trough at baseline by 54 ± 9% (t~(6)~= −4.99, P = 0.002). Like with DAMGO applied to the intact slice, DAMGO in CA1 only unmasked an earlier component visible as a notch in the waveform at baseline (example in [Fig. 6](#fig0030){ref-type="fig"}D). These observations indicate that MOR activation in CA1 alone is necessary and sufficient for the uncoupling of CA1 γ from slow γ in CA3, by suppression of the feed-forward IPSC, while leaving the EPSC intact.Fig. 6**DAMGO application to CA1 uncouples CA1 γ from CA3 slow γ. A.** Example of the effect of application of DAMGO to the CA1 area only, using the greased hair as diffusion barrier, on the power spectrum of recordings from CA3 (top panel) and CA1 (bottom panel), before (blue lines) and after local application of DAMGO (red lines). DAMGO in CA1 did not affect CA3 slow γ power or dominant frequency, but reduced the CA3-linked slow γ power peak in CA1. **B.** Example of the phase-locking value (PLV) between CA3 and CA1 recordings of slice in (A), for the slow γ band (black line) and the fast γ band (grey line). DAMGO application caused a strong reduction in the slow γ PLV but had no effect on the fast γ PLV. **C.** Histogram of the PLV for the slow γ band and fast γ band, at baseline (blue bars) and after DAMGO application to CA1 (red bars). Data are average and s.e.m. of 7 slices. **D.** Example of an ERP in CA1 time-zeroed by the CA3 trough-(dotted line) before (blue line) and after DAMGO application (red line). DAMGO application to CA3 suppressed the slow late ERP and enhances an earlier, faster ERP component (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).Fig. 6

4. Discussion {#sec0130}
=============

4.1. The effect of MOR activation on CA3-to-CA1 γ oscillation phase-coupling {#sec0135}
----------------------------------------------------------------------------

We assessed the effect of MOR activation on the phase-locking of CA1 γ oscillations to CA3 slow γ. In CA1 minislices, MOR activation by DAMGO caused a transient reduction of the dominant frequency. When applied to the bath or locally in CA3, DAMGO did not affect CA3 γ power consistently, but strongly reduced the dominant frequency. DAMGO applied in the bath or locally in CA1, reduced the suppressive effect of CA3 slow γ on intrinsic fast γ in CA1, reduced the PLV between CA3 slow γ and CA1 slow γ, and reduced the CA3 slow γ-triggered ERP in CA1. The effects of DAMGO were prevented by the competitive MOR antagonist CTAP and could not be mimicked by reducing CA3 slow γ dominant frequency with the benzodiazepine zolpidem. These experiments suggest that, under our experimental in vitro conditions, MOR activation in CA1 is necessary and sufficient to suppress the feed-forward inhibition-driven slow γ in CA1, which can cause the loss of phase-coupling between CA3 slow γ and CA1 slow γ.

4.2. MOR activation-mediated changes in CA3 slow γ {#sec0140}
--------------------------------------------------

Carbachol-induced γ oscillations in CA3 have been attributed to pyramidal-interneuron-network gamma (PING) ([@bib0090]). In the mouse hippocampus, DAMGO caused a strong suppression of carbachol-induced γ power, without an effect on dominant frequency ([@bib0120]), suggesting that PV+ interneuron-mediated IPSCs, subject to suppression by MOR activation, are a sine qua non for CA3 γ oscillations. However, in our hands, MOR activation did not affect CA3 γ power consistently, with both increases and decreases. This can be explained by inter-slice variability of the effect of MOR activation on Ivy cells ([@bib0150]). Ivy cells project perisomally and normally suppress pyramidal cell activity ([@bib0005]; [@bib0100]). MOR activation hyperpolarizes Ivy cells ([@bib0150]), which may increase pyramidal cell excitability and disinhibit local γ-generating networks, making the net effect of MOR activation on γ power in individual slices unpredictable. However, the DAMGO-induced strong reduction in dominant frequency was observed immediately and without exemption, suggesting significant differences between mice ([@bib0120]) and rat CA3. The deceleration of CA3 slow γ was independent of the change in γ power, suggesting that it is not related to IPSC amplitude ([@bib0010]). Larger intervals are likely due to prolonged IPSCs, as this could be mimicked by the benzodiazepine zolpidem ([@bib0135]), but MOR activation does not affect IPSC kinetics ([@bib0115]). Alternatively, deceleration of γ oscillations can be caused by a reduction of tonic depolarization of interneurons, e.g. by extra-synaptic tonic GABA~A~-ergic currents mediated by *δ* subunit-containing GABA~A~ receptors expressed on interneurons ([@bib0165]; [@bib0195]). It is also possible that MOR-expressing interneurons in CA3 normally inhibit interneurons that can generate a slower PING on their own, which is unmasked by MOR activation-mediated suppression of these interneurons ([@bib0145]; [@bib0185]).

Because the MOR antagonist CTAP had no effect on γ power and dominant frequency in both CA3 and isolated CA1, slices contain little natural ligand for MORs under our experimental in vitro conditions.

In CA1 minislices DAMGO had similar, bi-directional effects on the intrinsic CA1 fast γ power and reduced its dominant frequency slightly. The DAMGO-induced shift to lower frequencies will lead to an underestimation of the increase in CA1 fast γ power in intact slices.

4.3. MOR activation-mediated uncoupling of CA1 slow γ from CA3 slow γ {#sec0145}
---------------------------------------------------------------------

The experiments where DAMGO was applied after the competitive MOR antagonist CTAP, together with the local DAMGO applications, show that MOR activation in CA1 was necessary and sufficient to disrupt the phase-coupling between CA3 slow γ and CA1 slow γ. It is unlikely that this is the result of a reduced firing probability of CA3 pyramidal neurons ([@bib0180]), because the population spike in the CA3 waveforms selected for the CA3-CA1 ERP was identical before and after DAMGO.

CA1 slow γ emerges from synchronous feed-forward IPSCs, driven by CA3 slow γ-paced Schaffer collateral inputs ([@bib0035]; [@bib0085]; [@bib0090]). The PV + interneurons involved ([@bib0020]; [@bib0225]; [@bib0240]) express MORs ([@bib0080]; [@bib0215]). MOR activation inhibits selectively feed-forward GABAergic inhibitory postsynaptic responses in CA1 pyramidal neurons ([@bib0115]; [@bib0160]; [@bib0170]), through hyperpolarization of MOR-expressing interneurons by increasing outward currents ([@bib0115]; [@bib0215]; [@bib0230]) and through presynaptic inhibition ([@bib0045]; [@bib0050]; [@bib0115]). This can explain the MOR activation-induced suppression of phase-coupling between CA3 slow γ and CA1 slow γ. Given the slow IPSC kinetics of MOR-expressing Ivy cells ([@bib0100]), modulating their activity by MOR activation is unlikely to affect the γ phase-coupling ([@bib0005]). Because the suppression of intrinsic CA1 fast γ by CA3 slow γ reduced with the frequency of Schaffer collateral inputs ([@bib0195]), the loss of phase-coupling could alternatively be caused by the DAMGO-induced deceleration of CA3 slow γ. However, the deceleration of CA3 slow γ by zolpidem or local application of DAMGO to CA3, did not affect the phase-coupling. Furthermore when DAMGO was applied to CA1 only the phase-coupling reduced without deceleration of CA3 slow γ.

4.4. MOR activation-mediated facilitation of intrinsic CA1 fast γ {#sec0150}
-----------------------------------------------------------------

DAMGO application increased CA1 fast γ power in slices with clear intrinsic CA1 fast γ and unmasked intrinsic CA1 fast γ in slices with mainly CA3-driven CA1 slow γ. The effect of MOR activation in CA1 was similar to lesioning Schaffer collaterals ([@bib0195]) or inactivating CA3 with TTX ([Supplemental materials 2, panel C](#sec0180)), whereas low-intensity Schaffer collateral stimulation at slow γ frequencies, suppresses intrinsic CA1 fast γ ([@bib0195]). Since intrinsic CA1 fast γ is at least partly PING, dependent on pyramidal neuron firing ([@bib0195]), this suggests that in intact slices the intrinsic CA1 PING is suppressed by CA3 slow γ-driven feed-forward MOR-expressing interneuron activity. CA1 pyramidal cell excitability is suppressed by feed-forward activation of basket cells ([@bib0020]; [@bib0070]) and Ivy cells ([@bib0100]; [@bib0005]) amongst others. When rescued from this phasic and/or tonic suppression by MOR activation, intrinsic fast PING can emerge in the disinhibited CA1 network ([@bib0195]; [@bib0240]).

In addition, two interneuron populations that differ in IPSC decay rate and mutually inhibit each other, can give rise to fast γ and slow γ alternating within the same area ([@bib0145]; [@bib0185]). Similarly, an increased activity of an interneuron population with a faster IPSC decay rate ([@bib0130]) may contribute to the emergence of intrinsic CA1 fast γ in the presence of DAMGO.

4.5. Routing of information to CA1 by the θ phase {#sec0155}
-------------------------------------------------

During active behaviors, like exploration and object recognition, CA1 slow γ and fast γ are prominent on different θ cycles and at different θ phases ([@bib0065]; [@bib0205]). It is possible that the θ input from the medial septum mediates the switch between slow γ and fast γ, by varying the activity of feed-forward interneurons, which would vary the firing probability of CA1 pyramidal cells and, with it, the strength of intrinsic CA1 fast γ. This could be achieved by modulation of the strength of their excitatory inputs from CA3 ([@bib0180]) and/or by modulation of their excitability. Interneuron excitability is under control by GABAergic inputs from the medial septum, but this is not selective for feed-forward interneurons ([@bib0220]; [@bib0235]). A more feed-forward interneuron-specific θ-linked modulation could arise from the θ phase-modulated activity of enkephalin-expressing interneurons that target PV + interneurons ([@bib0030]; [@bib0105]) and release enkephalin upon burst firing induced by θ phased inputs ([@bib0105]). When MOR activation suppresses the CA3-CA1 phase-locking, the intrinsic CA1 fast γ can phase-lock with the fast γ in the MEC ([@bib0205]).

The θ phased routing of information from CA3 or MEC ([@bib0065]; [@bib0205]) has been linked to the encoding and retrieval of episodic and spatial memories ([@bib0125]; [@bib0140]) as it allows for segregation of information steams involved in encoding and recall of memory traces ([@bib0025]; [@bib0055]). It is therefore possible that the morphine-induced impairment of memory retrieval ([@bib0110]; [@bib0175]) is caused by a constant MOR activation that will disrupt the CA3 to CA1 phase-locking and segregation of information streams. This hypothesis should be assessed by testing the effect of selective MOR agonists on the θ modulation of CA1 γ oscillations and information routing.

5. Conclusions {#sec0160}
==============

MOR activation reduces the dominant frequency of CA3 slow γ and CA1 intrinsic fast γ, without consistent effect on γ power.

MOR activation in CA1 is sufficient and necessary to disrupt the phase-coupling between CA3 slow γ and CA1 slow γ.

The disruption is not caused by the reduction in dominant frequency of CA3 slow γ.

MOR-expressing CA1 interneurons, feed-forwardly activated by Schaffer collaterals, are likely to be responsible for the phase-coupling between CA3 and CA1 in vitro.

Theta-phased opioid release may dynamically modulate the routing of information between CA3-to-CA1 and MEC-to-CA1.
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